Kwells (Hyoscine Hydrobromide)

Hyoscine Hydrobromide is a muscarinic antagonist that competitively blocks acetylcholine at M1 and M3 receptors. This inhibition reduces vagal input to the stomach and dampens activity in the vestibular nuclei of the brain, thereby decreasing the sensation of nausea and the reflex that leads to vomiting.

The appropriate dose of Kwells is determined by the prescribing healthcare professional based on the patient’s age, weight, clinical condition, and response to therapy. Dosage instructions are provided on the prescription label and should be followed exactly as directed by the prescriber.

Safety data for Hyoscine Hydrobromide during pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss the risks and alternatives with their healthcare provider.

To order Kwells, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

The most common alternative to Hyoscine Hydrobromide is dimenhydrinate, another anticholinergic used for motion sickness. Kwells generally has a faster onset and a shorter duration of action, which can be advantageous for short trips. Dimenhydrinate may cause more pronounced drowsiness, while Kwells’ side‑effect profile often includes dry mouth and blurred vision.

Kwells should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date printed on the label.

Kwells is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the specific instructions on the prescription label. The tablet should be swallowed whole and not crushed or chewed unless otherwise directed by a healthcare professional.

Serious adverse reactions, although rare, include severe allergic responses such as rash or angioedema, marked tachycardia or cardiac arrhythmias, confusion, hallucinations, and severe constipation that could lead to bowel obstruction. Patients should seek immediate medical attention if any of these symptoms develop.

Kwells is contraindicated in individuals with known hypersensitivity to Hyoscine Hydrobromide or any other anticholinergic agents. It should also be avoided in patients with uncontrolled narrow‑angle glaucoma, severe urinary retention, prostatic hypertrophy causing obstruction, or significant gastrointestinal obstruction.